Rockwell Medical executed a distribution agreement with Nipro Medical, as part of Nipro Corporation Japan, a company in the global healthcare and medical device industry. Rockwell Medical will supply Nipro with the company’s liquid and dry acid and bicarbonate hemodialysis concentrates, as well as its dry acid concentrates mixer, for which Nipro has the right to distribute the company’s products globally, excluding the U.S. The agreement will remain in effect for two years with the option to extend the agreement for an additional one-year period and includes product purchasing minimums of $5.0M for the first year and incremental increases each subsequent year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMTI:
- Rockwell Med Unveils Updated Corporate Strategy Presentation
- Rockwell Medical raises 2024 revenue view to $90M-$94M from $95M-$98M
- Rockwell Medical reports Q2 EPS 5c vs. (12c) last year
- RMTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Rockwell Med Adjusts Agreement Terms and Reinforces Margin Goals
